InspireMD (NSPR) Stock: Buy, Sell, or Hold?
$0.64
-0.13 (-16.78%)
âŧ
5d:
-7.46%
30d:
+34.08%
90d:
-26.79%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (37%)
Quality Score
28/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$0.43 â $0.67
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-1.3x
Next 12M consensus est.
Wall Street Target
$3.33
+417.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.45 / $0.82
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: NSPR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When NSPR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: NSPR is currently trading at $0.64, which is considered slightly high relative to its 30-day fair value range of $0.43 to $0.67.
Technical Outlook: Technically, NSPR is in a downtrend. Immediate support is located at $0.45, while resistance sits at $0.82. Short-term momentum is weak, with the stock down 16.8% recently.
Market Sentiment: NSPR scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.33 (+417.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NSPR is in a downtrend. Immediate support is located at $0.45, while resistance sits at $0.82. Short-term momentum is weak, with the stock down 16.8% recently.
Market Sentiment: NSPR scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.33 (+417.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.43 -
$0.67
Company Quality Score
28/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
36.8%
Trading Range & Key Levels
30-Day Trading Range
$0.43 -
$0.67
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$0.45
Resistance Level
$0.82
Current Trend
Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-16.8%)
- BULLISH: Trading 417.5% below Wall St target ($3.33)
- WARNING: Composite score 28/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.33
Wall Street Target
$3.33
(+417.5%)
Revenue Growth (YoY)
-0.4%
Share NSPR Analysis
Share this live NSPR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NSPR)
Bearish
2 Retail Mentions
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary:
InspireMD reported Q3 earnings, trimmed costs after FDA approval, and announced a proposed public offering. Bearish sentiment on StockTwits expresses concerns over dilution from new shares and warrants.
Key Retail Themes:
Q3 earnings report
FDA approval of CGuard Prime
Cost-cutting measures
Proposed public offering
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 14, 2026 7:30 PM ET
Data refreshes hourly during market hours. Next update: 8:30 PM
Data refreshes hourly during market hours. Next update: 8:30 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NSPR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 59 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 49 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 37 SELL |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 33 SELL |
|
ATEC
Alphatec Holdings Inc |
STRONG BUY
14 analysts |
$13 | 74 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NSPR Research Pages
